BASi

Bioanalytical Systems, Inc. has made several changes to its board of directors and senior management. Richard M. Shepperd, president and chief executive officer of BASi, will retire from his position, effective February 12, 2010. The board intends to conduct a national search for a new chief executive officer.

Anthony S. Chilton, Ph.D., BASi’s chief operating officer, Scientific Services, will serve as interim president. Dr. Chilton has more than 30 years of experience as a scientist and executive in leading life sciences companies in England, Canada and the U.S. Prior to joining BASi in 2008, Dr. Chilton was in charge of early development programs at Atherogenics, Inc. and provided consulting and advisory services to pharmaceutical companies.

“The board would like to express its sincere appreciation to Mr. Shepperd for his strong leadership at a critical time in the company’s history,” said David W. Crabb, M.D. the chair of BASi’s Nominating Committee. “We are confident that Dr. Chilton has the background, knowledge and industry experience to effectively lead the company into the future.”

Also, A. Charlene Sullivan, Ph.D., has been elected as a director of the company, replacing William E. Baitinger who retired on January 13, 2010. “We are pleased to welcome Dr. Sullivan to the board and look forward to working with her,” Dr. Crabb said. The board of directors has not determined whether Dr. Sullivan will be named to any board committees.

Dr. Sullivan has served as an Associate Professor of Management at the School of Management and the Krannert Graduate School of Management at Purdue University since 1984. In addition, Dr. Sullivan has served as a financial analyst for the Indiana Gaming Commission since 1995.

Click here to find out more about BASi